Clincosm LogoSign in Get a demo

Solid Tumor

Showing NaN - NaN of 67
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma, Metastatic Castration-resistant Prostate Cancer, Urothelial Carcinoma Trial in United States (XL092,

Recruiting
  • Renal Cell Carcinoma
  • +3 more
  • Tucson, Arizona
  • +3 more
Mar 30, 2022

Solid Tumor Trial in United States (ORIC-101, Nab-paclitaxel)

Active, not recruiting
  • Solid Tumor
  • Palo Alto, California
  • +11 more
Mar 22, 2022

Metastatic Cancer, Solid Tumor, Cholangiocarcinoma Trial in United States (LYT-200, Anti-PD-1, Gemcitabine/nab-paclitaxel)

Recruiting
  • Metastatic Cancer
  • +4 more
  • Phoenix, Arizona
  • +15 more
Mar 9, 2022

NSCLC, Solid Tumor Trial in United States (Atezolizumab, Chemotherapy (Arm A Only), Tiragolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • Solid Tumor
  • Fort Myers, Florida
  • +6 more
Feb 16, 2022

Solid Tumor Trial in United States (PF-07284892, lorlatinib, binimetinib)

Recruiting
  • Solid Tumor
  • Orange, California
  • +6 more
Feb 15, 2022

Solid Tumor, Glioblastoma, NSCLC Trial in Nashville, Houston, Villejuif (TAS2940)

Recruiting
  • Solid Tumor
  • +3 more
  • Nashville, Tennessee
  • +2 more
Feb 25, 2022

Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)

Recruiting
  • Carcinoma
  • +18 more
  • PEN-866 Sodium
  • +3 more
  • Springdale, Arkansas
  • +15 more
Feb 16, 2022

Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)

Completed
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
  • +30 more
Feb 7, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Solid Tumor Trial in United States (PLX3397)

Completed
Has Results
  • Solid Tumor
  • Scottsdale, Arizona
  • +12 more
Dec 6, 2021

Subjects Treated With ACTR T Cell Product

Terminated
  • B Cell Lymphomas
  • +3 more
  • ACTR T Cell Product
  • Gilbert, Arizona
  • +15 more
Oct 4, 2021

Solid Tumor Trial in United States (BNT152, BNT153)

Recruiting
  • Solid Tumor
  • New Haven, Connecticut
  • +3 more
Sep 8, 2021

Solid Tumor Trial in Worldwide (LY3321367, LY3300054)

Active, not recruiting
  • Solid Tumor
  • Tucson, Arizona
  • +14 more
Sep 2, 2021

Solid Tumor Trial in Korea, Republic of, United States (RMC-4630, Cobimetinib, Drug: Osimertinib)

Active, not recruiting
  • Solid Tumor
  • Scottsdale, Arizona
  • +23 more
Aug 31, 2021

Metastasis in Lung, Metastasis in Liver, Solid Tumor Trial in United States (T3011, T3011 + pembrolizumab)

Recruiting
  • Metastasis in Lung
  • +3 more
  • T3011
  • T3011 + pembrolizumab
  • Phoenix, Arizona
  • +3 more
Aug 26, 2021

Solid Tumor Trial in United States (Epacadostat, Pembrolizumab, Oxaliplatin)

Completed
Has Results
  • Solid Tumor
  • Phoenix, Arizona
  • +15 more
Jul 13, 2021

Solid Tumor Trial in Worldwide (5-FU, Atezolizumab, Bevacizumab)

Completed
  • Solid Tumor
  • Palo Alto, California
  • +29 more
Jul 8, 2021

Solid Tumor, Colorectal Cancer Trial in United States (Magrolimab, Cetuximab)

Completed
Has Results
  • Solid Tumor
  • Colorectal Cancer
  • Los Angeles, California
  • +7 more
Feb 8, 2021

Solid Tumor, Lymphoma, Peripheral T-Cell Lymphoma Trial in United States (ALRN-6924)

Completed
  • Solid Tumor
  • +2 more
  • Birmingham, Alabama
  • +12 more
Jul 13, 2020

Solid Tumor, Non Small Cell Lung Cancer, Renal Cell Carcinoma Trial in Worldwide (LY3381916, LY3300054)

Terminated
  • Solid Tumor
  • +3 more
  • Indianapolis, Indiana
  • +11 more
Jun 8, 2020

Solid Tumor, HER-2 Protein Overexpression Trial in United States (ACTR T Cell Product, Trastuzumab)

Terminated
  • Solid Tumor
  • HER-2 Protein Overexpression
  • New Haven, Connecticut
  • +5 more
Mar 27, 2020

Solid Tumor Trial in Worldwide (Atezolizumab, GDC-0919)

Completed
  • Solid Tumor
  • Scottsdale, Arizona
  • +17 more
Oct 18, 2019

Solid Tumor, Hematologic Malignancies Trial in United States (BGJ398)

Terminated
Has Results
  • Solid Tumor
  • Hematologic Malignancies
  • Birmingham, Alabama
  • +55 more
May 28, 2019

Solid Tumor Trial in Sarasota, Baltimore, Nashville (RXDX-107)

Terminated
  • Solid Tumor
  • Sarasota, Florida
  • +2 more
Apr 24, 2019

Solid Tumor Trial in Worldwide (LY3022855, Durvalumab, Tremelimumab)

Completed
  • Solid Tumor
  • Denver, Colorado
  • +13 more
Jan 12, 2019